It looks a sound appointment. This firm has a lot of "big picture" positives on its side. (ageing population being the main one). I think the main risk behind an investment in AVE is execution of the strategy and this appointment should give the market confidence in that. I regard AVE as a "safe" investment.
I have been looking at CFU as a speccy recently. Like that whole alternative energy thing. Be interested on your general opinion on that segment. Risks / Other firms worth looking at etc. I'll post a Q in that forum.
AVE Price at posting:
$1.55 Sentiment: Buy Disclosure: Held
